Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€35.60

€35.60

4.620%
1.6
4.620%
€50.00

€50.00

 
02.05.24 / Tradegate WKN: A3D54P / Name: Corbus Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
16.04.24
-10.55%
buy
€50.00
15.04.24
-8.25%
buy
18.03.24
-4.81%
Your prediction

Corbus Pharmaceuticals Holding Inc. Stock

Corbus Pharmaceuticals Holding Inc. dominated the market today, gaining €1.60 (4.620%).
With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Corbus Pharmaceuticals Holding Inc..
With a target price of 50 € there is a positive potential of 40.45% for Corbus Pharmaceuticals Holding Inc. compared to the current price of 35.6 €.
Our community identified positive and negative aspects for Corbus Pharmaceuticals Holding Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Corbus Pharmaceuticals Holding Inc. stock. On the other hand our users think that "Management" could be a problem in the future.

Pros and Cons of Corbus Pharmaceuticals Holding Inc. in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Corbus Pharmaceuticals Holding Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Corbus Pharmaceuticals Holding Inc. 4.620% 13.376% 0.565% 27582.737% 27582.737% -17.045% -
Ardelyx Inc. 28.120% 34.723% 18.969% 89.624% 39.758% 44.250% -
Evolus Inc 10.280% 12.381% -5.600% 60.544% 30.387% 60.544% -
Salarius Pharmaceuticals Inc. 11.650% 7.981% 17.949% -67.606% -17.117% -98.248% -99.993%

Comments

Buy Corbus Pharmaceuticals Holdings Inc
Show more